Newer treatment modalities in diabetes, like GLP- 1 analogues, DPP-4 inhibitors, and bariatric surgical procedures, adress the topic of GV efficiently, and also investigating GV with the use of such drugs is promising in enhanced diabetes management [11]. The gene discussed is DPP4; the disease is diabetes mellitus.